BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 27300744)

  • 1. Catheter Ablation as First-Line Therapy for Atrial Fibrillation: Ready for Prime-Time?
    Carrizo AG; Morillo CA
    Curr Cardiol Rep; 2016 Jul; 18(8):71. PubMed ID: 27300744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).
    Stabile G; Bertaglia E; Senatore G; De Simone A; Zoppo F; Donnici G; Turco P; Pascotto P; Fazzari M; Vitale DF
    Eur Heart J; 2006 Jan; 27(2):216-21. PubMed ID: 16214831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early management of atrial fibrillation to prevent cardiovascular complications.
    Nattel S; Guasch E; Savelieva I; Cosio FG; Valverde I; Halperin JL; Conroy JM; Al-Khatib SM; Hess PL; Kirchhof P; De Bono J; Lip GY; Banerjee A; Ruskin J; Blendea D; Camm AJ
    Eur Heart J; 2014 Jun; 35(22):1448-56. PubMed ID: 24536084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.
    Nault I; Miyazaki S; Forclaz A; Wright M; Jadidi A; Jaïs P; Hocini M; Haïssaguerre M
    Eur Heart J; 2010 May; 31(9):1046-54. PubMed ID: 20332181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.
    Hakalahti A; Biancari F; Nielsen JC; Raatikainen MJ
    Europace; 2015 Mar; 17(3):370-8. PubMed ID: 25643988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
    Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
    Packer DL; Kowal RC; Wheelan KR; Irwin JM; Champagne J; Guerra PG; Dubuc M; Reddy V; Nelson L; Holcomb RG; Lehmann JW; Ruskin JN;
    J Am Coll Cardiol; 2013 Apr; 61(16):1713-23. PubMed ID: 23500312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Moretz K; Poole JE; Mascette A; Rosenberg Y; Jeffries N; Al-Khalidi HR; Lee KL;
    Am Heart J; 2018 May; 199():192-199. PubMed ID: 29754661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences.
    Kalman JM; Al-Kaisey AM; Parameswaran R; Hawson J; Anderson RD; Lim M; Chieng D; Joseph SA; McLellan A; Morton JB; Sparks PB; Lee G; Sanders P; Kistler PM
    Eur Heart J; 2023 Jul; 44(27):2447-2454. PubMed ID: 37062010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
    Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
    BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
    Mont L; Bisbal F; Hernández-Madrid A; Pérez-Castellano N; Viñolas X; Arenal A; Arribas F; Fernández-Lozano I; Bodegas A; Cobos A; Matía R; Pérez-Villacastín J; Guerra JM; Ávila P; López-Gil M; Castro V; Arana JI; Brugada J;
    Eur Heart J; 2014 Feb; 35(8):501-7. PubMed ID: 24135832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate Versus Rhythm Control for Atrial Fibrillation.
    Halsey C; Chugh A
    Heart Fail Clin; 2016 Apr; 12(2):193-203. PubMed ID: 26968665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.
    Verma A; Macle L; Cox J; Skanes AC;
    Can J Cardiol; 2011; 27(1):60-6. PubMed ID: 21329863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation: a meta-analysis of the randomized controlled trials.
    Parkash R; Tang AS; Sapp JL; Wells G
    J Cardiovasc Electrophysiol; 2011 Jul; 22(7):729-38. PubMed ID: 21332861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.